In this study, we firstly investigated the cytotoxicity of HHT on human NSCLC cell lines, A549 (wild type EGFR) and NCI-H1975 (H1975, mutant EGFR with L858R and T790M), using Gefitinib as a control. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.